TABLE 3.

Dengue IgM assay, hemagglutination inhibition assay, and reverse transcription-PCR results for all subjects selected for peptide response study in the ELISPOT IFN-γ assay

Patienta	Age (yr)	Sexb	Racec	Dengue type (grade)d	Day of onset	Result for IgMe	HIf	PCR resulte
Den0342*	35	F	M	DF	6	Pos	>10,240	Neg
Den0427	20	M	M	DF	6	Pos	5,120	Neg
Den0421*	22	M	M	DF	6	Pos	>10,240	Neg
Den0392*	23	F	M	DF	6	Pos	>10,240	Neg
Den0309	55	M	C	DF	7	Pos	>10,240	Neg
Den0301	25	M	M	DF	7	Pos	>10,240	Neg
Den0350	19	M	M	DF	7	Pos	640	Neg
Den0360*	25	M	M	DF	7	Pos	>10,240	Pos (DV1)
Den0228	55	F	C	DF	8	Pos	>10,240	Neg
Den0243*	23	M	C	DF	8	Pos	>10,240	Neg
Den0277	16	M	M	DF	8	Pos	1280	Neg
Den0347*	37	M	I	DF	9	Pos	>10,240	Neg
Den0437	38	M	M	DHF	5	Pos	1280	Neg
Den0235	38	M	I	DHF	5	Pos	>10,240	Neg
Den0381*	40	M	M	DHF	5	Pos	>10,240	Pos (DV1)
Den0454	16	M	I	DSS	5	Pos	640	Pos (DV3)
Den0416*	17	M	M	DHF	6	Pos	>10,240	Pos (DV1)
Den0351*	14	M	I	DHF	6	Pos	1280	Pos (DV1)
Den0429	16	M	M	DHF	6	Pos	>10,240	Neg
Den0446	16	F	I	DHF	6	Pos	>10,240	Pos (DV1)
Den0367	20	M	M	DHF	6	Pos	>10,240	Neg
Den0426	25	F	M	DSS	6	Pos	>10,240	Neg
Den0344*	19	M	M	DHF	7	Pos	>10,240	Pos (DV1)
Den0239	21	M	M	DHF	7	Pos	160	Neg
Den0355*	41	M	M	DHF	8	Pos	>10,240	Neg
Den0422	13	M	I	DHF	8	Pos	>10,240	Neg
Den0357	36	M	I	DHF	8	Pos	>10,240	Pos (DV1)
Den0356	24	F	C	DHF	8	Pos	>10,240	Neg
Den0380*	20	M	I	DHF	8	Pos	>10,240	Pos (DV1)
Den0466	33	F	C	DHF	8	Pos	>10,240	Neg
Den0438*	44	M	C	DHF	8	Pos	>10,240	Pos (DV1)
Den0386	14	F	C	DHF	9	Pos	1280	Neg

^a*, patient selected to study T-cell responses to individual peptides.

^bF, female; M, male.

^cC, Chinese; I, Indian; M, Malay.

^dDSS, dengue shock syndrome.

^ePos, positive; Neg, negative.

^fHI, hemagglutination inhibition. Values are reciprocal antibody titers.